| EPITOPE SUMMARY | |
|---|---|
| KLVALGINAV is a linear peptidic epitope (epitope ID ) studied as part of Genome polyprotein (UniProt:P27958) from Hepatitis C virus. This epitope has been studied for immune reactivity in publication(s), tested in T cell assays, B cell assay, MHC ligand assays and has 3D structure(s) and . | |
| CURATED EXPERIMENTAL DATA | |
|---|---|
MHC Ligand Assay(s) | |
| MHC molecule | Positive / All |
| HLA-A*02:01 | / |
| HLA-A*02:02 | / |
| HLA-A*02:03 | / |
| HLA-A*02:06 | / |
| HLA-A2 | / |
| HLA-B*07:02 | / |
| HLA-A*01:01 | / |
| HLA-A*03:01 | / |
| HLA-A*11:01 | / |
| HLA-A*31:01 | / |
| HLA-A*33:01 | / |
| HLA-A*68:01 | / |
| HLA-A*68:02 | / |
| HLA-B*08:01 | / |
| HLA-B*18:01 | / |
| HLA-B*35:01 | / |
| HLA-B*40:01 | / |
| HLA-B*40:02 | / |
| HLA-B*44:02 | / |
| HLA-B*44:03 | / |
| HLA-B*51:01 | / |
| HLA-B*53:01 | / |
| HLA-B*54:01 | / |
B Cell Assay(s) | |
| Assay Type | Positive / All |
| qualitative binding | / |
T Cell Assay(s) | |
| Assay Type | Positive / All |
| IFNg release | / |
| qualitative binding | / |
| IL-2 release | / |
| degranulation | / |
| cytotoxicity | / |
| dissociation constant KD | / |
| off rate | / |
| on rate | / |
| proliferation | / |
| TNFa release | / |
| IL-4 release | / |
| IL-17A release | / |
| IL-22 release | / |
| IL-10 release | / |
| 3D structure | / |
| activation | / |
| CCL4/MIP-1b release | / |
| TNF release | / |
| tumor burden after challenge after adoptive transfer | / |
| EXTERNAL RESOURCES | |
|---|---|
| Resource | Link |